R01 Fund LP and Related Entities File Form 3 for NovaBay Pharmaceuticals, Inc.

R01 Fund LP, along with R01 Capital LLC, R01 Capital Manager LLC, and Michael Kazley, have jointly filed a Form 3 with the SEC, disclosing their ownership of NovaBay Pharmaceuticals, Inc. securities. The filing includes details of the purchase of Series D and Series E Non-Voting Convertible Preferred Stock, which are convertible into common stock. The filing also notes that the securities may be deemed beneficially owned by the R01 Entities, although they disclaim beneficial ownership except to the extent of their pecuniary interest. The filing is made pursuant to a Joint Filing Agreement dated October 20, 2025.